Rebalix
Invesco · sheet of 4 September 2026
Invesco · sheet of 4 September 2026ETF sheet · official issuer and register data
Invesco US Treasury Bond 7-10 Year UCITS ETF GBP Hdg Dist
TRXS · IE00BF2FNB90 · class GBP Hdg Dist · GBP · domicile Ireland
Bonds · Government GBP · 7-10 years · EuropeGBP-hedged share classSFDR art. 6
Index tracked: Bloomberg US Treasury 7-10 Year Index
- TER
- 0.10%+ trans. 0.05%
- Fund size
- 1 bn EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 12.50%white list 100.00%
- Replication
- Physical
- Income
- Distributingquarterly
- Duration
- 6.87 yrsmedium (3–7 years)
Launch 11 Jan 2019 · costs from the KID as of 14 Aug 2026 · 14 securities held
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 14 Aug 2026
Dividend Policy: This Share Class declares and distributes a dividend on a quarterly basis. Investment objective: The objective of the Fund is to aim to track the Total Return performance of the Bloomberg US Treasury 7-10 Year Index (the "Index"), less fees, expenses and transaction costs.
Redemption and Dealing of Shares:
The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are traded. In exceptional circumstances investors…
Performance since series start (in euro) — base 100
11 Jan 2019 → 1 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +1.3% |
| 3 years | +8.7% |
| 5 years | −10.5% |
| 10 years | series too young |
| Since series start | +7.0% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 4.94% | 6.56% | 7.85% |
| Max drawdown | −5.74% | −8.74% | −26.73% |
| Sharpe | -1.24 | -0.60 | -1.00 |
| Sortino | -1.58 | -0.81 | -1.34 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · TRXS · IE00BF2FNB901
RebalixTRXS · IE00BF2FNB90 · sheet of 4 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years
Not honestly computable: hedged class: the issuer’s published index is unhedged — the gap would measure the exchange rate, not replication. We don’t show it
Fixed income — as declared by the issuer
Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 99.6%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Distributions · per share, in GBP
Frequency: quarterly · last 12 months: 1.4242 GBP (4.33% of NAV) · last ex-date 10 Sept 2026
| Year | Payments | Total (GBP) | Dividend yield |
|---|---|---|---|
| 2026 | 3 | 1.0797 | — |
| 2025 | 4 | 1.4076 | +4.28% |
| 2024 | 4 | 1.4195 | +4.09% |
| 2023 | 4 | 1.1905 | +3.40% |
| 2022 | 4 | 0.8466 | +1.99% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BF2FNB90
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BF2FNB90
Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · TRXS · IE00BF2FNB902